Idorsia has become the first drugmaker in the EU to claim approval for a drug for chronic insomnia in the dual orexin receptor antagonist class, ahead of rival drugs from Merck & Co and Eisai.

Nov 12 2024 Brief of respondents Anthony G. Brown, Attorney General of Maryland, et al. in opposition filed. Nov 25 2024 Reply of petitioners David Snope, et al. filed. (Distributed) Nov 26 2024 ...

Tissue engineering is a set of methods that can replace or repair damaged or diseased tissues with natural, synthetic, or semisynthetic tissue mimics. These mimics can either be fully functional ...